In Vivo Bioimaging for Monitoring Intratumoral Virus Activity

Area of Science:

• Translational Immune-Oncology
• Virotherapy Research
• Preclinical Research

Background:

• In vivo studies are crucial for immune-oncology and virotherapy.
• Bioluminescence imaging (BLI) is a key tool for visualizing tumors and monitoring treatment effects in oncology.
• BLI offers unique advantages for oncolytic virus research, including tracking tumor targeting, off-target replication, and intratumoral spread.

Purpose of the Study:

• To present a standardized, step-by-step bioluminescence imaging protocol.
• To enable effective monitoring of both tumors and oncolytic viruses in vivo.
• To provide a adaptable framework for researchers in translational oncology.

Main Methods:

• Development of a standard operating procedure for bioluminescence imaging.
• Detailed protocol for longitudinal monitoring of tumor growth kinetics.
• Methodology for visualizing and quantifying oncolytic virus activity and spread in vivo.

Main Results:

• Established a reliable protocol for in vivo tumor and virus monitoring.
• Demonstrated the utility of BLI for assessing oncolytic virus targeting and spread.
• Provided a foundation for preclinical biodistribution and pharmtox studies.

Conclusions:

• Bioluminescence imaging is an invaluable tool for oncolytic virus research.
• The presented protocol facilitates robust monitoring of virus-host interactions in vivo.
• This standardized approach supports the advancement of virotherapy and translational oncology.